To Study the Efficacy & Safety of Oral NA-921 (Bionetide) in Girls and Women with Rett Syndrome

NCT06849973 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

187

Enrollment

INDUSTRY

Sponsor class

Conditions

Rett Syndrome

Interventions

DRUG: Drug: Bionetide
DRUG: Placebo

Sponsor

Biomed Industries, Inc.